Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 4/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.57 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.57 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | GID4 | Q8IVV7 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | KCNN3 | Q9UGI6 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3962724 | 0.86 | ADRA1A (0.65) | ADRA1AADRA2AADRA1DADRA1BCYP2D6 | |
| SCHEMBL3955741 | 0.86 | ADRA1A (0.65) | ADRA1AADRA2AADRA1DADRA1BCYP2D6 | |
| SCHEMBL9814150 | 0.86 | ADRA1A (0.65) | ADRA1AADRA2AADRA1DADRA1BCYP2D6 | |
| SCHEMBL4204524 | 0.82 | ADRA1A (0.59) | ADRA1AADRA2AADRA1DADRA1BCYP2D6 | |
| SCHEMBL4208903 | 0.75 | ADRA1A (0.52) | ADRA1AADRA2AADRA1DADRA1BCYP2D6 | |
| SCHEMBL8086470 | 0.75 | ADRA1A (0.63) | ADRA1AADRA2AADRA1DADRA1BCYP2D6 | |
| SCHEMBL20874477 | 0.75 | GID4 (0.56) | ADRA1AADRA2AADRA1DADRA1BCYP2D6 | |
| SCHEMBL3171152 | 0.75 | ADRA1A (0.59) | ADRA1AADRA2AADRA1DADRA1BCYP2D6 | |
| SCHEMBL3668028 | 0.74 | ADRA2A (0.54) | ADRA1AADRA2AADRA1DADRA1BCYP2D6 | |
| SCHEMBL30108223 | 0.74 | ADRA1A (0.55) | ADRA1AADRA2AADRA1DADRA1BCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384113-B1 | POLYMER STABILIZER; LOW VOLATILITY; WEATHERABILITY; YELLOWING RESISTANCE | CYTEC TECHNOLOGY CORP. | 2002-05-07 | — | — | US | disclosed |
| US-20020028937-A1 | Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers | CYTEC TECHNOLOGY CORP. | 2002-03-07 | — | — | US | disclosed |
| US-6297377-B1 | Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers | CYTEC TECHNOLOGY CORPORATION | 2001-10-02 | — | — | US | disclosed |
| CN-1306521-A | Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers | CYTEC TECH CORP (US) | 2001-08-01 | — | — | CN | disclosed |
| EP-1089987-A1 | BENZOCYCLE-SUBSTITUTED TRIAZINE AND PYRIMIDINE ULTRAVIOLET LIGHT ABSORBERS | CYTEC TECHNOLOGY CORP. (US) | 2001-04-11 | — | — | EP | disclosed |
| WO-1999067225-A1 | BENZOCYCLE-SUBSTITUTED TRIAZINE AND PYRIMIDINE ULTRAVIOLET LIGHT ABSORBERS | CYTEC TECHNOLOGY CORP. (US) | 1999-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028937-A1 | Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers | ERCC5, ERCC4, ERCC2 | ADRA1A 2126/4885ADRA2A 1260/4885ADRA1D 2712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.